| Atlas of clinically distinct cell states and ecosystems across human solid tumors BA Luca, CB Steen, M Matusiak, A Azizi, S Varma, C Zhu, J Przybyl, ... Cell 184 (21), 5482-5496. e28, 2021 | 148 | 2021 |
| The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma CB Steen, BA Luca, MS Esfahani, A Azizi, BJ Sworder, BY Nabet, ... Cancer cell 39 (10), 1422-1437. e10, 2021 | 135 | 2021 |
| A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talk AJ Gentles, ABY Hui, W Feng, A Azizi, RV Nair, G Bouchard, DA Knowles, ... Genome biology 21, 1-22, 2020 | 40 | 2020 |
| Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia BA Benard, LB Leak, A Azizi, D Thomas, AJ Gentles, R Majeti Nature Communications 12 (1), 7244, 2021 | 37 | 2021 |
| Enasidenib drives human erythroid differentiation independently of isocitrate dehydrogenase 2 R Dutta, TY Zhang, T Köhnke, D Thomas, M Linde, E Gars, M Stafford, ... The Journal of clinical investigation 130 (4), 1843-1849, 2020 | 27 | 2020 |
| Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience A Azizi, A Ediriwickrema, R Dutta, SA Patel, W Shomali, B Medeiros, ... Leukemia & Lymphoma, 1-8, 2020 | 26 | 2020 |
| The TRACE-Seq method tracks recombination alleles and identifies clonal reconstitution dynamics of gene targeted human hematopoietic stem cells R Sharma*, DP Dever*, CM Lee*, A Azizi* (Co-First), Y Pan, J Camarena, ... Nature Communications 12 (1), 472, 2021 | 23 | 2021 |
| The cell type–specific 5hmC landscape and dynamics of healthy human hematopoiesis and TET2-mutant preleukemia Y Nakauchi*, A Azizi* (Co-First), D Thomas, MR Corces, A Reinisch, ... Blood cancer discovery 3 (4), 346-367, 2022 | 20 | 2022 |
| Clinically-relevant cell type cross-talk identified from a human lung tumor microenvironment interactome AJ Gentles, ABY Hui, W Feng, A Azizi, RV Nair, DA Knowles, A Yu, ... bioRxiv, 637306, 2019 | 4 | 2019 |
| Convergent epigenetic evolution drives relapse in acute myeloid leukemia K Nuno*, A Azizi* (Co-First), T Koehnke, C Lareau, A Ediriwickrema, ... eLife 13, e93019, 2024 | 2 | 2024 |
| RUNX1 loss renders hematopoietic and leukemic cells dependent on IL-3 and sensitive to JAK inhibition AC Fan, Y Nakauchi, L Bai, A Azizi, KA Nuno, F Zhao, T Köhnke, ... The Journal of Clinical Investigation 133 (19), 2023 | 2 | 2023 |
| Use of enfortumab vedotin in an HIV-positive patient with urothelial carcinoma A Azizi, R Houshyar, N Mar Journal of Oncology Pharmacy Practice 28 (5), 1226-1229, 2022 | 2 | 2022 |
| Atlas of clinically-distinct cell states and cellular ecosystems across human solid tumors BA Luca, CB Steen, A Azizi, M Matusiak, J Przybyl, N Neishaboori, ... Cancer Research 80 (16_Supplement), 3443-3443, 2020 | 2 | 2020 |
| Chromatin Accessibility Analysis Reveals Epigenetic Evolution Is a Common Mechanism of Relapse in Acute Myeloid Leukemia KA Nuno, A Azizi, T Koehnke, A Ediriwickrema, MR Corces, R Majeti Blood 138, 677, 2021 | 1 | 2021 |
| Characterization of patients requiring inpatient hospital ethics consults-A single center study A Mahadevan*, A Azizi* (Co-First), C Dastur, S Stern-Nezer, J Nahmias, ... Plos one 19 (4), e0296763, 2024 | | 2024 |
| A single cell framework identifies functionally and molecularly distinct multipotent progenitors in adult human hematopoiesis A Ediriwickrema, Y Nakauchi, A Fan, T Köhnke, X Hu, BA Luca, YE Kim, ... bioRxiv, 2024.05. 07.592983, 2024 | | 2024 |
| Dissecting Lineage and Cell State-Specific Epigenetic Evolution in Relapsed Acute Myeloid Leukemia A Azizi, K Nuno, R Majeti Blood 142, 5680, 2023 | | 2023 |
| Assessing the Impact of Language Barriers on Telehealth Utilization and Subsequent Clinical Outcomes in Patients with Cancer During the COVID-19 Pandemic and Beyond A Azizi, A Mahadevan, J Arora, E Chiao, S Tanjasiri, F Dayyani OSF Preprints, 2023 | | 2023 |
| Partial Reversal of Anosmia Following Platinum-Based Chemotherapy in a Patient With Colorectal Adenocarcinoma A Mahadevan, A Azizi, N Bhandarkar, F Dayyani Cureus 15 (9), 2023 | | 2023 |
| Distribution of immune-related adverse events (irAEs) across genitourinary (GU) malignancies. N Mar, M Slaught, D Kaakour, A Azizi, JB Valerin Journal of Clinical Oncology 40 (6_suppl), 480-480, 2022 | | 2022 |
